Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zelboraf
Pharma
Daiichi Sankyo scores $182M from Novartis patent settlement
In 2017, Daiichi's former subsidiary Plexxikon alleged that Novartis stepped on its Zelboraf patents with its GSK-acquired medicine Tafinlar.
Zoey Becker
Dec 6, 2023 11:13am
AstraZeneca, Takeda, Biocon-Viatris and more—Fierce Pharma Asia
Jul 30, 2021 5:17am
Novartis on the hook for $178M, maybe more, in patent case
Jul 23, 2021 6:30am
Roche's Tecentriq triplet nabs melanoma OK
Jul 31, 2020 1:49am
Roche's Tecentriq, on top of targeted drugs, stalls melanoma
Apr 27, 2020 12:01am
Roche's Tecentriq rebounds in melanoma with 3-drug cocktail win
Dec 13, 2019 10:10am
